177 related articles for article (PubMed ID: 18322167)
61. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.
Wedemeyer H; He XS; Nascimbeni M; Davis AR; Greenberg HB; Hoofnagle JH; Liang TJ; Alter H; Rehermann B
J Immunol; 2002 Sep; 169(6):3447-58. PubMed ID: 12218168
[TBL] [Abstract][Full Text] [Related]
62. Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling.
Radziewicz H; Ibegbu CC; Hon H; Bédard N; Bruneau J; Workowski KA; Knechtle SJ; Kirk AD; Larsen CP; Shoukry NH; Grakoui A
J Immunol; 2010 Mar; 184(5):2410-22. PubMed ID: 20100932
[TBL] [Abstract][Full Text] [Related]
63. Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline.
Conry SJ; Meng Q; Hardy G; Yonkers NL; Sugalski JM; Hirsch A; Davitkov P; Compan A; Falck-Ytter Y; Blanton RE; Rodriguez B; Harding CV; Anthony DD
J Infect Dis; 2012 Apr; 205(7):1131-41. PubMed ID: 22351942
[TBL] [Abstract][Full Text] [Related]
64. Relationship between regulatory T cells and the combination of pegylated interferon and ribavirin for the treatment of chronic hepatitis type C.
Akiyama M; Ichikawa T; Miyaaki H; Motoyoshi Y; Takeshita S; Ozawa E; Miuma S; Shibata H; Taura N; Nakao K
Intervirology; 2010; 53(3):154-60. PubMed ID: 20068349
[TBL] [Abstract][Full Text] [Related]
65. Associations between serum lipids and hepatitis C antiviral treatment efficacy.
Ramcharran D; Wahed AS; Conjeevaram HS; Evans RW; Wang T; Belle SH; Yee LJ;
Hepatology; 2010 Sep; 52(3):854-63. PubMed ID: 20690192
[TBL] [Abstract][Full Text] [Related]
66. Hepatic compartmentalization of exhausted and regulatory cells in HIV/HCV-coinfected patients.
Barrett L; Trehanpati N; Poonia S; Daigh L; Sarin SK; Masur H; Kottilil S
J Viral Hepat; 2015 Mar; 22(3):281-8. PubMed ID: 25174689
[TBL] [Abstract][Full Text] [Related]
67. Patient-derived hepatitis C virus inhibits CD4⁺ but not CD8⁺ T lymphocyte proliferation in primary T cells.
MacParland SA; Chen AY; Corkum CP; Pham TN; Michalak TI
Virol J; 2015 Jun; 12():93. PubMed ID: 26084511
[TBL] [Abstract][Full Text] [Related]
68. Comparative effectiveness of 8- and 12-week ledipasvir/sofosbuvir regimens for HCV infection.
Ojha RP; MacDonald BR; Chu TC; Fasanmi EO; Moore JD; Stewart RA
Antivir Ther; 2018; 23(7):585-592. PubMed ID: 29969099
[TBL] [Abstract][Full Text] [Related]
69. Influence of amantadine on CD81 expression on lymphocytes in chronic hepatitis C.
Welker MW; von Wagner M; Ochs D; Zimmer V; Hofmann WP; Piiper A; Hartmann RW; Herrmann E; Zeuzem S; Kronenberger B
Dig Liver Dis; 2010 Oct; 42(10):735-40. PubMed ID: 20457015
[TBL] [Abstract][Full Text] [Related]
70. TCF1
Wieland D; Kemming J; Schuch A; Emmerich F; Knolle P; Neumann-Haefelin C; Held W; Zehn D; Hofmann M; Thimme R
Nat Commun; 2017 May; 8():15050. PubMed ID: 28466857
[TBL] [Abstract][Full Text] [Related]
71. IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses.
Han JW; Sung PS; Hong SH; Lee H; Koh JY; Lee H; White S; Maslow JN; Weiner DB; Park SH; Jeong M; Heo J; Ahn SH; Shin EC
J Hepatol; 2020 Jul; 73(1):72-83. PubMed ID: 32088322
[TBL] [Abstract][Full Text] [Related]
72. Naïve CD4+ T Cell Lymphopenia and Apoptosis in Chronic Hepatitis C Virus Infection Is Driven by the CD31+ Subset and Is Partially Normalized in Direct-Acting Antiviral Treated Persons.
Auma AWN; Shive CL; Lange A; Damjanovska S; Kowal C; Zebrowski E; Pandiyan P; Wilson B; Kalayjian RC; Canaday DH; Anthony DD
Front Immunol; 2021; 12():641230. PubMed ID: 33912168
[TBL] [Abstract][Full Text] [Related]
73. Adaptive Natural Killer Cell Functional Recovery in Hepatitis C Virus Cured Patients.
Mele D; Oliviero B; Mantovani S; Ludovisi S; Lombardi A; Genco F; Gulminetti R; Novati S; Mondelli MU; Varchetta S
Hepatology; 2021 Jan; 73(1):79-90. PubMed ID: 32281670
[TBL] [Abstract][Full Text] [Related]
74. Memory-like HCV-specific CD8
Hensel N; Gu Z; Sagar ; Wieland D; Jechow K; Kemming J; Llewellyn-Lacey S; Gostick E; Sogukpinar O; Emmerich F; Price DA; Bengsch B; Boettler T; Neumann-Haefelin C; Eils R; Conrad C; Bartenschlager R; Grün D; Ishaque N; Thimme R; Hofmann M
Nat Immunol; 2021 Feb; 22(2):229-239. PubMed ID: 33398179
[TBL] [Abstract][Full Text] [Related]
75. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
[TBL] [Abstract][Full Text] [Related]
76. Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy.
Rosen HR; Weston SJ; Im K; Yang H; Burton JR; Erlich H; Klarquist J; Belle SH;
Hepatology; 2007 Aug; 46(2):350-8. PubMed ID: 17659573
[TBL] [Abstract][Full Text] [Related]
77. Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals.
Burchill MA; Golden-Mason L; Wind-Rotolo M; Rosen HR
J Viral Hepat; 2015 Dec; 22(12):983-91. PubMed ID: 26482547
[TBL] [Abstract][Full Text] [Related]
78. Cutting edge: programmed death-1 up-regulation is involved in the attrition of cytomegalovirus-specific CD8+ T cells in acute self-limited hepatitis B virus infection.
Zhang JY; Zhang Z; Jin B; Zhang SY; Zhou CB; Fu JL; Wang FS
J Immunol; 2008 Sep; 181(6):3741-4. PubMed ID: 18768824
[TBL] [Abstract][Full Text] [Related]
79. Alterations in T-lymphocyte subsets in the airways of asthmatic patients with active hepatitis C virus infection.
Kanazawa H; Yoshikawa J
Respiration; 2006; 73(3):318-23. PubMed ID: 16179822
[TBL] [Abstract][Full Text] [Related]
80. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
Vali B; Jones RB; Sakhdari A; Sheth PM; Clayton K; Yue FY; Gyenes G; Wong D; Klein MB; Saeed S; Benko E; Kovacs C; Kaul R; Ostrowski MA
Eur J Immunol; 2010 Sep; 40(9):2493-505. PubMed ID: 20623550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]